← SynDRA
FOSINOPRILAT
SynDRA canonical compound SYN0000942 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ACE |
|---|
| Mechanism of action | angiotensin converting enzyme inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 INHIBITOR
Drug classes
- Angiotensin-converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitor
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- ACE INHIBITORS, PLAIN
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- Fosinopril diacid
- Fosfenopril
- Fosinopril related compound a
- Fosinoprilic acid
- PU6BA2D2MD
- SO 27,519
- SO-27519
- SQ 27,519
- SQ-27519
- S312EY6ZT8
- SQ-27,519
- fosinopril related compound a (usp-rs)
- fosinopril sodium impurity a (ep impurity)
- fosfenopril
- fosinopril related compound a (usp impurity)
- Fosinoprilatum
- CHEBI:116962
- RefChem:57081
- DTXCID60820726
- Fosinoprilat [USAN:INN]
- Fosinoprilatum [INN-Latin]
- UNII-S312EY6ZT8
- KS8
- Fosinopril impurity A CRS
- Fosinoprilat (USAN/INN)
- FOSINOPRILAT [INN]
- FOSINOPRILAT [USAN]
- SCHEMBL124537
- SCHEMBL677955
- FOSINOPRIL DIACID [MI]
- GTPL6457
- orb3132269
- BDBM50018849
- AKOS032953851
- DA-63591
- HY-107352
- CS-0028200
- NS00126388
- C21542
Reported adverse events
- Bronchospasm
- Chest pain
- Angioedema
- Arthralgia
- Cough
- Gout
- Lymphadenopathy
- Neutropenia
- Pancreatitis
- Tinnitus
- Urticaria
- Cerebral infarction
Look up FOSINOPRILAT in the interactive SynDRA portal →